These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26629346)

  • 21. [Impact of systolic blood pressure on visit-to-visit blood pressure variability in middle-aged and elderly people].
    Chen SH; Liu YH; Cai J; Wang AT; Ma YJ; Li XL; Gao JL; Zhao XQ; Wu SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):219-23. PubMed ID: 23879947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study.
    Wang A; Li Z; Yang Y; Chen G; Wang C; Wu Y; Ruan C; Liu Y; Wang Y; Wu S
    Ther Clin Risk Manag; 2016; 12():1191-6. PubMed ID: 27536123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease.
    Kawai T; Ohishi M; Ito N; Onishi M; Takeya Y; Yamamoto K; Kamide K; Rakugi H
    J Hypertens; 2013 Jul; 31(7):1387-95; discussion 1395. PubMed ID: 24006037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Glucose Metabolism Is Associated with Visit-to-Visit Blood Pressure Variability in Participants without Cardiovascular Disease.
    Sasaki N; Ozono R; Fujiwara S; Maeda R; Kihara Y
    Int J Hypertens; 2018; 2018():5126270. PubMed ID: 29850224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes.
    Moosaie F; Mouodi M; Sheikhy A; Fallahzadeh A; Deravi N; Rabizadeh S; Fatemi Abhari SM; Meysamie A; Dehghani Firouzabadi F; Nakhjavani M; Esteghamati A
    J Diabetes Metab Disord; 2021 Dec; 20(2):1715-1723. PubMed ID: 34900821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes.
    Eguchi K; Ishikawa J; Hoshide S; Pickering TG; Schwartz JE; Shimada K; Kario K
    Am J Hypertens; 2009 Jan; 22(1):46-51. PubMed ID: 18833198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visit-to-visit variability in systolic blood pressure is a novel risk factor for the progression of coronary artery calcification.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Tomiyasu K; Nakano K; Hasegawa G; Nakamura N
    Hypertens Res; 2013 Nov; 36(11):996-9. PubMed ID: 23823173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease.
    Nakano C; Morimoto S; Nakahigashi M; Kusabe M; Ueda H; Someya K; Ichihara A; Iwasaka T; Shiojima I
    Hypertens Res; 2015 Mar; 38(3):193-8. PubMed ID: 25471235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes.
    Bouchi R; Babazono T; Mugishima M; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    J Diabetes Investig; 2012 Mar; 3(2):148-55. PubMed ID: 24843558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of diabetic renal function impairment in the first decade after diagnosed of diabetes mellitus is correlated with high variability of visit-to-visit systolic and diastolic blood pressure: a case control study.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    BMC Nephrol; 2017 Mar; 18(1):99. PubMed ID: 28330451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients.
    Ghuman NK; Saadah LM; Al Najjar MS; Shaheen DY; Am SI; Al Ali MM
    Clin Med Insights Endocrinol Diabetes; 2015; 8():67-72. PubMed ID: 26441485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
    Proietti M; Romiti GF; Olshansky B; Lip GYH
    Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease.
    Nagai M; Hoshide S; Ishikawa J; Shimada K; Kario K
    J Hypertens; 2012 Aug; 30(8):1556-63. PubMed ID: 22728907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.